Post-Induction Minimal Residual Disease Measured By Flow Cytometry and Deep Sequencing of Mutant GATA1 Are Both Significant Prognostic Factors for Children with Myeloid Leukemia and Down Syndrome: A Nationwide Prospective Study of the Japanese Pediatric Leukemia/Lymphoma Study Group
Takashi Taga(Erasmus MC), Daisuke Tomizawa(National Center For Child Health and Development), Asahito Hama(Nagoya University), Hidefumi Hiramatsu(Kyoto University), Akira Shimada(Tohoku University), Takako Miyamura(The University of Osaka), Katsuyoshi Koh(Saitama Children's Medical Center), Daisuke Hasegawa(Icahn School of Medicine at Mount Sinai), Souichi Adachi(Kyoto University), Etsuro Ito(Okayama University), Tsutomu Toki(Hirosaki University), Yoshiko Hashii(The University of Osaka), Shiro Tanaka(University of Tokyo Health Sciences), Daiichiro Hasegawa(Kobe Children's Hospital), Tomohiko Taki(Kyorin University), Hiroshi Moritake(University of Miyazaki), Akiko Saito(Nagoya University Hospital), Hiroyuki Takahashi(Children's Cancer Association of Japan), Shotaro Iwamoto(Mie University), Hideki Nakayama(National Hospital Organization Kyushu Cancer Center), Kiminori Terui(Hirosaki University)
Cited by 1
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
|Nature Medicine|2018|577
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel
|Blood|2012|575
NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity
|Nature Genetics|2016|473
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia
|Journal of Clinical Oncology|2015|383